(Q45001390)

English

Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Roberto Labianca

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Rossana Berardi

9

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Mario Scartozzi

10

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Stefano Cascinu

object named as

Stefano Cascinu

1

0 references

author name string

Eva Galizia

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Francesco Ferraù

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Francesca Pucci

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Rosa Rita Silva

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Gabriele Luppi

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Giordano Domenico Beretta

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

37-43

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthra

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Chemotherapy for advanced gastric cancer: across the years for a standard of care

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1424-8

21 January 2018

Identifiers

10.1007/S00280-010-1424-8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45001390&oldid=2207038079"